ProfileGDS5678 / 1443451_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 50% 51% 51% 44% 50% 50% 49% 50% 50% 51% 50% 51% 50% 51% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2558250
GSM967853U87-EV human glioblastoma xenograft - Control 23.2179451
GSM967854U87-EV human glioblastoma xenograft - Control 33.2167951
GSM967855U87-EV human glioblastoma xenograft - Control 42.9792744
GSM967856U87-EV human glioblastoma xenograft - Control 53.1591450
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2997150
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.248649
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1924850
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1799950
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2144251
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2036250
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1780451
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.216350
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2097151